These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1296494)

  • 1. [Evaluation of efficacy and tolerability of ioversol in intravenous urography. A comparative double-blind study versus iopamidol].
    Joffre F; Rousseau H; Aziza R
    Ann Radiol (Paris); 1992; 35(4 Pt 2):288-92. PubMed ID: 1296494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ioversol 300: clinical study in pediatric intravenous urography].
    Montagne J; Adamsbaum C
    Ann Radiol (Paris); 1992; 35(4 Pt 2):307-10. PubMed ID: 1296498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ioversol in intravenous excretory urography. Evaluation of radiographic quality, patient tolerance and safety in four clinical studies.
    Jahn H; Müller-Späth R
    Ann Radiol (Paris); 1992; 35(4 Pt 2):297-302. PubMed ID: 1296496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of efficacy and tolerability of ioversol in intravenous urography].
    Lemaître L
    Ann Radiol (Paris); 1992; 35(4 Pt 2):303-6. PubMed ID: 1296497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of clinical tolerability and diagnostic efficacy of ioversol 350 in UIV. A randomized double-blind study of ioversol 350 versus iohexol 350].
    Voegeli E; Woessmer B
    Ann Radiol (Paris); 1992; 35(4 Pt 2):293-6. PubMed ID: 1296495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary European intravenous clinical experience with a new, low osmolar, nonionic contrast medium: ioversol (Optiray).
    Le Mignon MM; Azau C; Arthaud A; Bonnemain B
    Eur J Radiol; 1991; 13(2):126-33. PubMed ID: 1743190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous excretory urography using Optiray in office urology.
    Koncz PM
    Int Urol Nephrol; 1995; 27(3):257-60. PubMed ID: 7591587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind clinical study comparing the safety, tolerance and efficacy of ioversol and iohexol in intravenous urography.
    Colthurst JR; Chan O; Creagh M; Gordon P; Guy R; Muncey F; Ayers AB
    Clin Radiol; 1990 Sep; 42(3):174-6. PubMed ID: 2208927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unequal doses of ioversol versus diatrizoate for urography.
    Baker MK; Kopecky KK; Bogan M; Wass JL
    Urol Radiol; 1990; 12(3):168-72. PubMed ID: 2281582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ioversol 300 and iopamidol 300 in "whole body" computed tomography. A double-blind clinical trial].
    Chagnaud C; Moulin G; Delannoy L; Gaubert JY; Haddad D; Bartoli JM; Kasbarian M
    Ann Radiol (Paris); 1992; 35(4 Pt 2):276-9. PubMed ID: 1296491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of iopromide for excretory urography.
    Newhouse JH; Landman J; Lang E; Amis ES; Goldman S; Khazan R; Leder R; Hedgcock M
    Invest Radiol; 1994 May; 29 Suppl 1():S68-73. PubMed ID: 8071049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iodixanol in intravenous urography: a comparison of iodixanol 270 mgI/ml, iodixanol 320 mgI/ml and iopamidol 300 mgI/ml (NIOPAM).
    Conroy RM; Bjartveit K; Sheppick A; Long U; Masterson J
    Clin Radiol; 1994 May; 49(5):337-40. PubMed ID: 8013200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical studies with a new non-ionic contrast medium (iopamidol) in intravenous pyelography in aged patients].
    Miyakawa M; Nishio Y; Nonomura M; Matsuda T; Ueda M; Kaku S; Okamoto Y; Shitiri Y; Shirahase T; Nakamura K
    Hinyokika Kiyo; 1987 Mar; 33(3):465-70. PubMed ID: 2441581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, parallel group trial of iomeprol, iohexol and iopamidol in intravenous urography.
    Harding JR; Bertazzoli M; Spinazzi A
    Br J Radiol; 1995 Jul; 68(811):712-5. PubMed ID: 7640924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of diagnostic efficacy and clinical tolerability of ioversol in "whole body" computed tomography in children. A non comparative phase III trial].
    Panuel M; Devred P; Faure F; Bourlière-Najean B; Ternier F; Le Bail C
    Ann Radiol (Paris); 1992; 35(4 Pt 2):280-3. PubMed ID: 1296492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ioversol for intravenous urography: a comparison study.
    Kaufman AJ; Concepcion R; Kirchner FK; McDougal WS; Winfield AC
    Urol Radiol; 1990; 12(1):56-60. PubMed ID: 2333674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind study comparing the safety, tolerability, and efficacy of ioversol 320 and iopamidol-300 in cerebral angiography.
    Ringel K; Kuehn J
    Invest Radiol; 1989 Jun; 24 Suppl 1():S48-51. PubMed ID: 2687196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical profile of ioversol. A metaanalysis of 57 randomized, double-blind clinical trials.
    Floriani I; Ciceri M; Torri V; Tinazzi A; Jahn H; Noseda A
    Invest Radiol; 1996 Aug; 31(8):479-91. PubMed ID: 8854194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind comparative study on the contrast quality, tolerance and safety of ioversol 300 versus iohexol 300 in central venous angiography (C.V. DSA).
    Rieser R; Beinborn W; Ney N
    Ann Radiol (Paris); 1992; 35(4 Pt 2):311-4. PubMed ID: 1296499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of hypo-osmolar contrast media in urography--results of an interindividual, randomized double-blind study].
    Heep HW; Müller-Lüdecke H
    Rontgenpraxis; 1984 Jun; 37(6):209-12. PubMed ID: 6385304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.